S everal guidance cues operate in verte brates, with the most prominent group be ing chemokines. In vitro, many chemokines induce directional cell migration when offered as gradients. However, the best established in vivo example of chemokine function does not rely on gradients: During extravasation from the blood stream, chemokines immobilized on the luminal surface of blood vessels (1 3) trigger the local arrest of leukocytes, which precedes their exit into the tissue (4) . Less is known about how chemokines act beyond the endothelium (5) , and, especially within lymphatic organs, chemokines seem to rather cause random motility than di rectional responses (5) . The sparse body of exist ing evidence for directional guidance is largely inferred from the migratory trajectories of cells without information on actual chemokine dis tribution (6 8) . Only two studies visualized che mokine gradients in parenchymal organs (9, 10) , and the CODcept that grndients trigger directional migration bas not been addressed with manip ulative approaches.
We used mature dendritic cells (OCs) that migrate from the dermal interstitium into affer ent lymphatic vessels (LVs) (11) as a model sys tern to study chernokine function in situ. To track DCs en route to LVs, we used tissue explants of split mouse ears (12) . Within minutes after additioo of exogenous DCs onto exposed der mal tissue, the cells entered the interstitium and approached nearby LVs in a directed manner (Fig. l , A to D, and movie Sl). Single cell track ing within the almost planar anatomy of the mouse ear (fig. Sl) revealed that cells switched from noodirectional to increasingly directional persistent movement toward the vessel at a distance of about 90 J.Ull from the vessel wall (Fig. 1, B to D, and fig. 82 ). When located be tween two LVs, DCs occasionally extended protrusions toward both vessels, indicating the simultaneous presence of two conflicting sig nals. There the cells often spanned distances of more than 50 J.UI1 before they retracted ooe protrusion and finally entered one of the vessels ( Fig. IE and signals were CODsiderably lower than in the per meabilized tissue, the interstitial distn"bution of CCL21 became apparent CCL21 peaked oo the vessel wall and appeared to grndually fade with increasing distance froo1 the vessel (Fig. 2C ).
To quantitatively analyze these interstitial gradients, we first ensured that our detection method amplified the chemokine signal linearly ( fig. 84 ) and then measured the averaged in tensity of interstitial CCL21 staining as a time tioo of distance from the LV margin. Integration of data from multiple ear sheets revealed that the mean CCL2I signal steeply decayed around the vessel and flattened in the intervessel area ( Fig. 2D and fig. 85 , A and B). Stainings for CCL19 with identical secondary reagents revealed a uniform pattern of background signal in both CCL19 deficient and oootrol tissues. This back ground signal invariably approached the leveled out CCL21 signal remote from the vessel ( fuded at a distance of 75 to 90 IJlil from the vessel wall ( Fig. 20) and thus matched the mi&rratory behavior of the cells that increased directionality in a similar perimeter around the vessel as we have shown above (Fig. 1 C) . To estimate bow well the detected gradients comply with the dis tnbution of LVs within the dermis, we calcu lated distance maps of afferent LVs over large areas. We found that a cell that is randomly lo caliz.ed within the interstitium would need to travel an average distance of 47 ± 3 J.im to reach the nearest LV ( fig. 86, A and B) and that 92% of the interstitial space lies within a 90 IJlil perimeter around the LV netwmk ( fig. S6C ). In accordance with this, endpoint analysis of in travasation assays only occasionally revealed few cells that were left "stranded" in the middle be tween vessels with large spacing (fig. 860 ). These data demonstrate a relative invariability of the intervessel distance and imply that the range of the CCL21 gradient is very well adapted to the distribution ofLVs in the skin. We next challenged our correlative evidence for DC guidance by a CCL21 gradient using experimental manipulations. To test to what de gree a continuous release of CCL21 is required to maintain the gradient, we extensively washed the ear explants and performed migration assays in the presence of brefeldin A to terminate pos Sible chemokine secretion tium LVs. Because we previously found that CCL21 can be proteolytical ly cleaved at the C terminus by a DC associated protease (18), we also pharmacol!Jbrically blocked this putative cleavage event, which might cause solubilization of CCL21. In both cases, we found that cells still approached LVs (fig. S7, A and B ) and conclude that a continuous release ofCCL21 is dispensable for directed DC migration within the approximate 2 hour time window of our as says. This suggests that the functionally active CCL21 gradient is stored within the homeostatic dermis.
In contrast to CCL19, CCL21 has a highly charged C terminal extension that binds glyco saminoglycans (GAGs) and is thought to im mobilize the chemolcine to extracellular matrix or cell surfaces (18, 19) . Our previous findings together with the fact that we could detect CCL21 gradients by histological methods, which necessarily include washing steps where unbound proteins are removed, were consistent with the assumption that CCL21 in the dermis is not sol -a. o E 0~ z uble. We therefore performed a series of experi ments in which we perturbed the distribution of endogenous CCL21 by addition of exogenous chemokine. To this end, we pre incubated ear explants with an excess of exogenous recombi nant CCL21 , washed them to remove the solu ble CCL21 fraction, and quantified the impact on gradient shapes and DC migration. We found that exogenous CCL21 diffusely localized with in the dermal interstitium and thereby masked and flattened the endogenous CCL21 gradients (Fig. 3A and fig. S8A ). In the pretreated ex plants, a laJb>e fiaction of DCs was misguided within the interstitium and ultimately remained scattered remote from the vessels (Fig. 3 , B to D; fig. S8B ; and movie S4). Additionally, pre treatment of the explants with a C terminally truncated version ofCCL21, which is incapable of binding GAGs (19) , as well as with a GAG binding but nonsignaling mutant did not change the migratory pattern of the cells (Fig. 3D and  fig. S8C ). To exclude that exogenous CCL21 af fects DC migration nonspecifically, for example, by masking electrostatic interactions, we pre treated ear explants with exogenous CXCL13 and CXCLI2, which also bind GAGs ( do not trigger CCR7, and saw no significant ef fects on DC migration (Fig. 3D and fig. S8C ). Together, these findings establish the functional activity of the immobilized CCL21 gradients that we identified before and show that, although DCs carry the receptor for and can respond to CXCL12, CCL21 gradients dominate. In addition, the che mokine pattern appears not to be determined by the distribution of CCL21 binding sites but most likely by the diffusion range of CCL21, which is trapped by sugar residues once it is released from the LVs (21) .
CCL21 was shown to bind via its C terminal domain sulfated sugars like heparin, heparan, dermatan, and chondroitin sulfates with low nano molar affinities (19, 22, 23) , potentially explain ing the observed long retention times of CCL21 within the dermis and the inability of C terminally truncated CCL21 to outcompete the endogenous gradients. To test which of the sugar moieties are involved in the immobilization of CCL21, we pretreated ear explants with sugar degrading enzymes and found that heparitinase, which ef fectively removed heparan sulfates ( fig. S9A) , severely changed the CCL21 pattern. Quantifica tions revealed an almost complete flattening of the gradient and a drop to signal levels similar to control stainings, whereas tissue integrity was not affected (Fig. 3E and figs. S5G, S9B , and S10A). Consequently, DC migration in heparitinase treated explants was severely diminished (Fig.  3F and fig. S10B ). Heparan sulfate distribution patterns in untreated dermis did not match these of CCL21 ( fig. S9A ), corroborating the concept that not the tissue binding sites for CCL21 but rather its distribution range determines the shape of the CCL21 gradient. These findings demon strate that, like in the lumen of blood endothe lium (2), interstitial CCL21 is immobilized to heparan sulfate residues, which either decorate cell surfaces or interstitial matrix components. This immobilized chemokine fraction is sufficient to guide intravasation of DCs, whereas adhesion molecules of the integrin family are dispensable for path finding (24) .
The term "haptotaxis" was originally intro duced to describe cell migration along adhesive gradients, a phenomenon that was successfully constituted in vitro but still lacks direct in vivo support (25) . Interstitial guidance by heparan sul fate immobilized chemokine gradients, as dem onstrated here, can be viewed as a second variant of haptotaxis. The facts that (i) many chemokines bind GAGs (26) , (ii) GAG interaction is impor tant for the leukocyte recruiting activity of some chemokines upon instillation into animals (27) , and (iii) leukocytes have the ability to migrate along immobilized chemokine gradients in vitro (28, 29) suggest that haptotaxis could be a wide ly used principle. Because immobilized gradients are insensitive to mechanical perturbations, they certainly constitute a robust and stable infrastruc ture for cellular guidance, whereas attraction by soluble gradients might be rather transient in nature.
